mGlu5 receptor availability in youth at risk for addictions: effects of vulnerability traits and cannabis use
Open Access
- 15 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 45 (11), 1817-1825
- https://doi.org/10.1038/s41386-020-0708-x
Abstract
The excitatory neurotransmitter glutamate has been implicated in experience-dependent neuroplasticity and drug-seeking behaviors. Type 5 metabotropic glutamate (mGlu5) receptors might be particularly important. They are critically involved in synaptic plasticity and their availability has been reported to be lower in people with alcohol, tobacco, and cocaine use disorders. Since these reductions could reflect effects of drug use or pre-existing traits, we used positron emission tomography to measure mGlu5 receptor availability in young adults at elevated risk for addictions. Fifty-nine participants (age 18.5 ± 0.6) were recruited from a longitudinal study that has followed them since birth. Based on externalizing traits that predict future substance use problems, half were at low risk, half were at high risk. Cannabis use histories varied markedly and participants were divided into three subgroups: zero, low, and high use. Compared to low risk volunteers, those at elevated risk had lower [11C]ABP688 binding potential (BPND) values in the striatum, amygdala, insula, and orbitofrontal cortex (OFC). Cannabis use by risk group interactions were observed in the striatum and OFC. In these regions, low [11C]ABP688 BPND values were only seen in the high risk group that used high quantities of cannabis. When these high risk, high cannabis use individuals were compared to all other participants, [11C]ABP688 BPND values were lower in the striatum, OFC, and insula. Together, these results provide evidence that mGlu5 receptor availability is low in youth at elevated risk for addictions, particularly those who frequently use cannabis.Keywords
Funding Information
- Fonds de Recherche du Québec - Santé (35282, 991027, 981055)
- Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (MOP-133537, MOP-97910, 133537, MOP-133537, MOP-97910, MOP-44072, MOP-133537)
- Fonds de Recherche du Québec-Société et Culture (2002-RS-79238, 2009-RG-124779, 2002-RS-79238, 2009-RG-124779)
- Gouvernement du Canada | Social Sciences and Humanities Research Council of Canada (839-2000-1008, 410-99-1048, 410-99-1048, 839-2000-1008)
This publication has 56 references indexed in Scilit:
- Kinase interest you in treating incubated cocaine‐craving? A hypothetical model for treatment intervention during protracted withdrawal from cocaineGenes, Brain and Behavior, 2017
- Metabotropic glutamate receptor, mGlu5, mediates enhancements of hippocampal long-term potentiation after environmental enrichment in young and old miceNeuropharmacology, 2017
- Methamphetamine Addiction Vulnerability: The Glutamate, the Bad, and the UglyBiological Psychiatry, 2016
- Dissecting the Signaling Pathways Involved in the Crosstalk between Metabotropic Glutamate 5 and Cannabinoid Type 1 ReceptorsMolecular Pharmacology, 2016
- The mGlu5 receptor regulates extinction of cocaine-driven behavioursDrug and Alcohol Dependence, 2014
- The mGluR5 Antagonist MTEP Dissociates the Acquisition of Predictive and Incentive Motivational Properties of Reward-Paired Stimuli in MiceNeuropsychopharmacology, 2010
- Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seekingBehavioural Brain Research, 2009
- Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in ratsPsychopharmacology, 2004
- Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbensProceedings of the National Academy of Sciences of the United States of America, 2002
- Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant miceNature Neuroscience, 2001